연구성과로 돌아가기
2023 연구성과별 연구자 정보 (68 / 2675)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Lee, Jung Il | Lee, JI | 8 | Yonsei Univ, Gangnam Severance Hosp, Coll Med, Seoul, South Korea | AAH-8473-2020 | Lee, Hyun Woo | 0000-0002-0142-1398 | LEE, JUNG IL | mfyuen@hku.hk; | |
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Kweon, Young Oh | Kweon, YO | 9 | Kyungpook Natl Univ, Daegu, South Korea | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Weltman, Martin | Weltman, M | 10 | Nepean Hosp, Penrith, Australia | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Harrison, Stephen A. | Harrison, SA | 11 | Pinnacle Clin Res Ctr, San Antonio, TX USA | GON-3283-2022 | Harrison, Stephen | mfyuen@hku.hk; | |||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Neuschwander-Tetri, Brent A. | Neuschwander-Tetri, BA | 12 | St Louis Univ, Sch Med, St Louis, MO USA | IST-8116-2023 | Neuschwander-Tetri, Brent | mfyuen@hku.hk; | |||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Cusi, Kenneth | Cusi, K | 13 | Univ Florida, Gainesville, FL USA | ADV-2401-2022 | Cusi, Kenneth | mfyuen@hku.hk; | |||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Loomba, Rohit | Loomba, R | 14 | UCSD, NAFLD Res Ctr, Div Gastroenterol, La Jolla, CA USA | AAE-7831-2019 | Loomba, Rohit | mfyuen@hku.hk; | |||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Given, Bruce D. | Given, BD | 15 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Christianson, Dawn R. | Christianson, DR | 16 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Garcia-Medel, Eric | Garcia-Medel, E | 17 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Yi, Min | Yi, M | 18 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Hamilton, James | Hamilton, J | 19 | Arrowhead Pharmaceut Inc, Pasadena, CA USA | mfyuen@hku.hk; | |||||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Yuen, Man-Fung | Yuen, MF | 20 | 교신저자 | Univ Hong Kong, Queen Mary Hosp, Hong Kong, Peoples R China | C-4466-2009 | Yuen, Richard Man Fung | mfyuen@hku.hk; | ||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Yuen, Man-Fung | Yuen, MF | 20 | 교신저자 | Sch Clin Med, Dept Med, Hong Kong, Peoples R China | C-4466-2009 | Yuen, Richard Man Fung | mfyuen@hku.hk; | ||
| A phase I/II study of ARO-HSD, an RNA interference therapeutic, for the treatment of non-alcoholic steatohepatitis | Yuen, Man-Fung | Yuen, MF | 20 | 교신저자 | Univ Hong Kong, Queen Mary Hosp, State Key Lab Liver Res, Hong Kong, Peoples R China | C-4466-2009 | Yuen, Richard Man Fung | mfyuen@hku.hk; |
페이지 이동: